Cutaneous T-Cell Lymphoma (CTCL) Active Not Recruiting Phase Trials for Brentuximab vedotin (DB08870)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01396070Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression LevelTreatment